Clinical trial
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With…
NCT00004114 · Jonsson Comprehensive Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00004114 |
|---|---|
| Title | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer |
| Official title | Non-Myeloablative Chemotherapy Followed by Unrelated Allogeneic Stem Cell Transplantation in Patients With Advanced Hematologic Malignancies: A Pilot Study |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Myelodysplastic Syndromes |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, cyclophosphamide, cytarabine, fludarabine phosphate, peripheral blood stem cell transplantation |
| Enrollment | 0 |
| First posted | Feb 16, 2004 |
| Last update posted | Jul 31, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: